Article | Published:

Human calprotectin is an iron-sequestering host-defense protein

Nature Chemical Biology volume 11, pages 765771 (2015) | Download Citation

Abstract

Human calprotectin (CP) is a metal-chelating antimicrobial protein of the innate immune response. The current working model states that CP sequesters manganese and zinc from pathogens. We report the discovery that CP chelates iron and deprives bacteria of this essential nutrient. Elemental analysis of CP-treated growth medium establishes that CP reduces the concentrations of manganese, iron and zinc. Microbial growth studies reveal that iron depletion by CP contributes to the growth inhibition of bacterial pathogens. Biochemical investigations demonstrate that CP coordinates Fe(II) at an unusual hexahistidine motif, and the Mössbauer spectrum of 57Fe(II)-bound CP is consistent with coordination of high-spin Fe(II) at this site (δ = 1.20 mm/s, ΔEQ = 1.78 mm/s). In the presence of Ca(II), CP turns on its iron-sequestering function and exhibits subpicomolar affinity for Fe(II). Our findings expand the biological coordination chemistry of iron and support a previously unappreciated role for CP in mammalian iron homeostasis.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Accessions

Protein Data Bank

References

  1. 1.

    , , & Biological Inorganic Chemistry: Structure and Reactivity (University Science Books, 2007).

  2. 2.

    Nutritional immunity: host's attempt to withhold iron from microbial invaders. J. Am. Med. Assoc. 231, 39–41 (1975).

  3. 3.

    , , & How pathogenic bacteria evade mammalian sabotage in the battle for iron. Nat. Chem. Biol. 2, 132–138 (2006).

  4. 4.

    & Nutritional immunity: transition metals at the pathogen-host interface. Nat. Rev. Microbiol. 10, 525–537 (2012).

  5. 5.

    & Iron in infection and immunity. Cell Host Microbe 13, 509–519 (2013).

  6. 6.

    , , & Transition metal ions at the crossroads of mucosal immunity and microbial pathogenesis. Front. Cell. Infect. Microbiol. 4, 2 (2014).

  7. 7.

    , & The zinc-reversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants. J. Infect. Dis. 164, 137–142 (1991).

  8. 8.

    et al. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319, 962–965 (2008).

  9. 9.

    et al. Nutrient metal sequestration by calprotectin inhibits bacterial superoxide defense, enhancing neutrophil killing of Staphylococcus aureus. Cell Host Microbe 10, 158–164 (2011).

  10. 10.

    , & Calcium ion gradients modulate the zinc affinity and antibacterial activity of human calprotectin. J. Am. Chem. Soc. 134, 18089–18100 (2012).

  11. 11.

    , , & High-affinity manganese coordination by human calprotectin is calcium dependent and requires the histidine-rich site formed at the dimer interface. J. Am. Chem. Soc. 135, 775–787 (2013).

  12. 12.

    et al. Molecular basis for manganese sequestration by calprotectin and roles in the innate immune response to invading bacterial pathogens. Proc. Natl. Acad. Sci. USA 110, 3841–3846 (2013).

  13. 13.

    , , & Contributions of the S100A9 C-terminal tail to high-affinity Mn(II) chelation by the host-defense protein human calprotectin. J. Am. Chem. Soc. 135, 17804–17817 (2013).

  14. 14.

    , , , & Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations. Biochim. Biophys. Acta 1763, 1298–1306 (2006).

  15. 15.

    et al. Manganese-binding properties of human calprotectin under conditions of high and low calcium: X-ray crystallographic and advanced electron paramagnetic resonance spectroscopic analysis. J. Am. Chem. Soc. 137, 3004–3016 (2015).

  16. 16.

    , & The crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting α-helices can determine specific association of two EF-hand proteins. J. Mol. Biol. 370, 887–898 (2007).

  17. 17.

    & Mn2+ and bacterial pathogenesis. Front. Biosci. 9, 1035–1042 (2004).

  18. 18.

    & Manganese transport and the role of manganese in virulence. Annu. Rev. Microbiol. 60, 187–209 (2006).

  19. 19.

    , , , & Interplay between manganese and zinc homeostasis in the human pathogen Streptococcus pneumoniae. Metallomics 3, 38–41 (2011).

  20. 20.

    et al. A manganese-rich environment supports superoxide dismutase activity in a Lyme disease pathogen, Borrelia burgdorferi. J. Biol. Chem. 288, 8468–8478 (2013).

  21. 21.

    & Manganese acquisition and homeostasis at the host-pathogen interface. Front. Cell. Infect. Microbiol. 3, 91 (2013).

  22. 22.

    & The stability of transition-metal complexes. J. Chem. Soc. 3192–3210 (1953).

  23. 23.

    & Manganese and microbial pathogenesis: sequestration by the mammalian immune system and utilization by microorganisms. ACS Chem. Biol. 10, 641–651 (2015).

  24. 24.

    & Manganese and defenses against oxygen toxicity in Lactobacillus plantarum. J. Bacteriol. 145, 442–451 (1981).

  25. 25.

    & The ubiquity of iron. ACS Chem. Biol. 7, 1477–1481 (2012).

  26. 26.

    in Physical Methods in Bioinorganic Chemistry: Spectroscopy and Magnetism (ed. Que, L., Jr.) 287–319 (University Science Books, 2000).

  27. 27.

    & Mössbauer Spectroscopy. (Springer, 1971).

  28. 28.

    , , & Motional effects in the Mössbauer spectra of iron(II) hexammines. Chem. Phys. Lett. 5, 105–108 (1970).

  29. 29.

    et al. Exchange coupling in an isostructural series of face-sharing bioctahedral complexes [LMII(μ-X)3M(II)L]BPh4 (M = Mn, Fe, Co, Ni, Zn; X = Cl, Br; L=1,4,7-trimethyl-1,4,7-triazacyclononane). Inorg. Chem. 36, 2834–2843 (1997).

  30. 30.

    & Metallation and mismetallation of iron and manganese proteins in vitro and in vivo: the class I ribonucleotide reductases as a case study. Metallomics 4, 1020–1036 (2012).

  31. 31.

    , , & A new cell-permeable fluorescent probe for Zn2+. J. Am. Chem. Soc. 122, 5644–5645 (2000).

  32. 32.

    Characterization and application of ferrozine iron reagent as a ferrous iron indicator. Anal. Chem. 48, 1197–1201 (1976).

  33. 33.

    Ferrozine—a new spectrophotometric reagent for iron. Anal. Chem. 42, 779–781 (1970).

  34. 34.

    , , , & The crystal structures of human S100A12 in apo form and in complex with zinc: new insights into S100A12 oligomerization. J. Mol. Biol. 391, 536–551 (2009).

  35. 35.

    , & Zinc-binding site of an S100 protein revealed. Two crystal structures of Ca2+-bound human psoriasin (S100A7) in the Zn2+-loaded and Zn2+-free states. Biochemistry 38, 1695–1704 (1999).

  36. 36.

    , , & The crystal structures of human S100B in the zinc- and calcium-loaded state at three pH values reveal zinc ligand swapping. Biochim. Biophys. Acta 1813, 1083–1091 (2011).

  37. 37.

    et al. Zinc sequestration by the neutrophil protein calprotectin enhances Salmonella growth in the inflamed gut. Cell Host Microbe 11, 227–239 (2012).

  38. 38.

    , , & Complexation of iron(III) and iron(II) by citrate. Implications for iron speciation in blood plasma. J. Inorg. Biochem. 78, 175–184 (2000).

  39. 39.

    & Metal-binding characteristics and role of iron oxidation in the ferric uptake regulator from Escherichia coli. Biochemistry 44, 13553–13559 (2005).

  40. 40.

    , , & Calorimetric studies on the tight binding metal interactions of Escherichia coli manganese superoxide dismutase. J. Biol. Chem. 279, 27339–27344 (2004).

  41. 41.

    , , , & Spectroscopic and structural characterization of the [Fe(imidazole)6]2+ cation. Inorg. Chem. 42, 5771–5777 (2003).

  42. 42.

    , , & Hexakis(1H-imidazole-κN3)iron(II) sulfate–1H-imidazole (1/2). Acta Crystallogr. Sect. E Struct. Rep. Online 67, m1600–m1601 (2011).

  43. 43.

    , , & A component of innate immunity prevents bacterial biofilm development. Nature 417, 552–555 (2002).

  44. 44.

    et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432, 917–921 (2004).

  45. 45.

    , , , & Feo –transport of ferrous iron into bacteria. Biometals 19, 143–157 (2006).

  46. 46.

    , & Escherichia coli K-12 ferrous iron–uptake mutants are impaired in their ability to colonize the mouse intestine. FEMS Microbiol. Lett. 108, 111–115 (1993).

  47. 47.

    et al. Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs. Infect. Immun. 81, 2697–2704 (2013).

  48. 48.

    et al. Iron acquisition and virulence in Helicobacter pylori: a major role for FeoB, a high-affinity ferrous iron transporter. Mol. Microbiol. 37, 274–286 (2000).

  49. 49.

    Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine). Anal. Biochem. 40, 450–458 (1971).

Download references

Acknowledgements

Research on Fe(II)-CP in the Nolan Laboratory was supported by the Office of the Director of the US National Institutes of Health (NIH grant 1DP2OD007045, E.M.N.), the MIT Center for Environmental Health Sciences (NIH P30-ES002109, E.M.N.), the Sloan Foundation and the Kinship Foundation (Searle Scholar Award, E.M.N.). T.G.N. is a recipient of the NSF Graduate Research Fellowship. Any opinion, findings and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the NSF. We thank R. Laufhutte for performing the ICP-MS and ICP-OES analyses, A.J. Wommack for synthesizing ZP1 and J. Stubbe and members of her laboratory for guidance on the 55Fe experiments and for providing the facilities to work with radioactivity. We acknowledge the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for providing the S. aureus USA300 JE2 parent strain of the Nebraska Transposon Mutant Library (NTML) that is supported by NIH NIAID grant HHSN272200700055C.

Author information

Affiliations

  1. Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

    • Toshiki G Nakashige
    •  & Elizabeth M Nolan
  2. Department of Chemistry, Pennsylvania State University, University Park, Pennsylvania, USA.

    • Bo Zhang
    •  & Carsten Krebs
  3. Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, USA.

    • Carsten Krebs

Authors

  1. Search for Toshiki G Nakashige in:

  2. Search for Bo Zhang in:

  3. Search for Carsten Krebs in:

  4. Search for Elizabeth M Nolan in:

Contributions

T.G.N. and E.M.N. designed the research. T.G.N. prepared the ICP-MS, ICP-OES and Mössbauer spectroscopy samples and conducted the microbial growth assays, 55Fe uptake studies, analytical SEC, ZP1 Kd,Fe(II) determination and metal-ion competition experiments. B.Z. and C.K. performed and analyzed the Mössbauer spectroscopy. T.G.N. and E.M.N. analyzed the results and wrote the paper.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Elizabeth M Nolan.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Results, Supplementary Tables 1–14, Supplementary Figures 1–23 and Supplementary Note.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nchembio.1891

Further reading